Check out our free and informative ezines and sign up now
The FDA published a final guidance Oct. 28 addressing the use of nucleic acid tests (NATs) to screen blood donors for HIV-1 and hepatitis C virus (HCV).
This article is viewable by subscribers only. To view this article, please select an option below.
ePublishing :: CMS, Hosting & Web Development | © Copyright